Carole Ann Simpson, MD | |
Usa Meddac Bavaria, Cmr 411 Bldg 700, Apo, AE 09112 | |
(314) 590-2900 | |
Not Available |
Full Name | Carole Ann Simpson |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | Usa Meddac Bavaria, Apo, Armed Forces Europe |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063480648 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 34717 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Carole Ann Simpson, MD Usa Meddac Bavaria, Cmr 411 Bldg 700, Apo, AE 09112 Ph: () - | Carole Ann Simpson, MD Usa Meddac Bavaria, Cmr 411 Bldg 700, Apo, AE 09112 Ph: (314) 590-2900 |
News Archive
Nymox Pharmaceutical Corporation announced today that the Company is nearing completion of a new multi-center U.S. long-term follow-up study of NX-1207, its investigational drug for the treatment of benign prostatic hyperplasia (BPH). Nymox expects to report final results and statistical analysis for the study in the next 1-2 weeks. The new study concerns assessment of the 48-60 month efficacy and benefits of a single treatment of NX-1207.
Can a new liposomal bupivacaine product provide long-lasting nerve block with a single injection? An initial study in humans shows promise-but also some "confusing results," reports the November issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
A novel partnership between Massachusetts General Hospital and Massachusetts Institute of Technology is addressing three major challenges in clinical medicine – improving the diagnosis of disease, developing new approaches to prevent and treat infectious and autoimmune diseases, and developing more accurate methods of diagnosing and treating major neurodegenerative and psychiatric diseases. While individual collaborations between MGH and MIT investigators are nothing new, this formalized strategic partnership is designed to accelerate the development of diagnostic tools and therapies.
There has been much uncertainty regarding the risk of cancer associated with taking hormone replacement therapy (HRT) for the menopause. An analysis of all available evidence published in The Lancet today shows that HRT, even when taken for only a few years, significantly increases the risk of developing the two most common types of ovarian cancer.
Results from a phase II clinical trial indicate a novel drug may provide a treatment option for chronic myeloid leukemia (CML) patients who do not respond to current therapies, researchers from The University of Texas M. D. Anderson Cancer Center report today at the 51st Annual Meeting of the American Society of Hematology.
› Verified 9 days ago
Dr. Kathryn Taylor Gattone, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 86 Mdg, Unit 3215, Ramstein Ab, Apo, AE 09012 Phone: 601-850-3607 | |
Dr. Steven Jai Novek, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Cmr 427, Box 850, Apo, AE 09630 Phone: 044-471-6682 | |
Dr. Nicole Marie Thomas, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 86 Mdg, Unit 3215, Apo, AE 09094 Phone: 210-857-9007 | |
Ryan Flanagan, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 3310,0, Apo, AE 09180 Phone: 314-590-5762 | |
Dr. Eric W Smith-jones, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-7405 | |
Dr. Ashley Monique Taylor, MD Pediatrics Medicare: Medicare Enrolled Practice Location: Unit 5115, Apo, AE 09461 Phone: 314-226-8707 |